Literature DB >> 19371354

Cerebellar cortical demyelination in the murine cuprizone model.

Thomas Skripuletz1, Jens-Heiko Bussmann, Viktoria Gudi, Paraskevi N Koutsoudaki, Refik Pul, Darius Moharregh-Khiabani, Maren Lindner, Martin Stangel.   

Abstract

In multiple sclerosis, demyelination occurs beside the white-matter structures and in the cerebral and cerebellar cortex. We have previously shown that, in the cuprizone model, demyelination is present not only in the corpus callosum but also in the cerebral cortex. Here, we have performed a detailed analysis of the dynamics of de- and remyelination in the cerebellar cortex and white matter at nine timepoints in two cerebellar regions. To induce demyelination, C57BL/6 mice were fed with 0.2% cuprizone for 12 weeks followed by a recovery of 8 weeks. Both cortex and white-matter structures were significantly demyelinated after 12 weeks of cuprizone feeding. Remyelination occurred after withdrawal of cuprizone but was less prominent in the more caudal cerebellar region. Microglia infiltration was prominent in all analyzed cerebellar areas, preceding demyelination by approximately 2-4 weeks, and was delayed in the more caudal cerebellar region. Astrogliosis was also seen but did not reach the extent observed in the cerebrum. In summary, cuprizone feeding provides an excellent model for the investigation of de- and remyelination processes in the cerebellar cortex and white matter. Furthermore, demyelination, microglia and astrocyte changes were different in the cerebellum as compared with the cerebrum, indicating region-dependent pathomechanisms.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19371354     DOI: 10.1111/j.1750-3639.2009.00271.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  34 in total

1.  Demyelination and remyelination in anatomically distinct regions of the corpus callosum following cuprizone intoxication.

Authors:  Andrew J Steelman; Jeffrey P Thompson; Jianrong Li
Journal:  Neurosci Res       Date:  2011-10-12       Impact factor: 3.304

Review 2.  The innate immune system in demyelinating disease.

Authors:  Lior Mayo; Francisco J Quintana; Howard L Weiner
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

Review 3.  Restoring the balance between disease and repair in multiple sclerosis: insights from mouse models.

Authors:  Robert H Miller; Sharyl L Fyffe-Maricich
Journal:  Dis Model Mech       Date:  2010-07-20       Impact factor: 5.758

4.  The Effect of Melatonin on Behavioral, Molecular, and Histopathological Changes in Cuprizone Model of Demyelination.

Authors:  Gelareh Vakilzadeh; Fariba Khodagholi; Tahereh Ghadiri; Amir Ghaemi; Farshid Noorbakhsh; Mohammad Sharifzadeh; Ali Gorji
Journal:  Mol Neurobiol       Date:  2015-08-27       Impact factor: 5.590

5.  Epimedium flavonoids ameliorate neuropathological changes and increases IGF-1 expression in C57BL/6 mice exposed to cuprizone.

Authors:  Mengru Liang; Yongyan Chen; Li Zhang; Lin Li; Guangliang Chen; Linlin Yin
Journal:  Neurochem Res       Date:  2015-02-07       Impact factor: 3.996

6.  Anatomical Distribution of Cuprizone-Induced Lesions in C57BL6 Mice.

Authors:  Johannes Goldberg; Tim Clarner; Cordian Beyer; Markus Kipp
Journal:  J Mol Neurosci       Date:  2015-06-12       Impact factor: 3.444

7.  Protective Effect of a cAMP Analogue on Behavioral Deficits and Neuropathological Changes in Cuprizone Model of Demyelination.

Authors:  Gelareh Vakilzadeh; Fariba Khodagholi; Tahereh Ghadiri; Marzieh Darvishi; Amir Ghaemi; Farshid Noorbakhsh; Ali Gorji; Mohammad Sharifzadeh
Journal:  Mol Neurobiol       Date:  2014-08-17       Impact factor: 5.590

Review 8.  Age-related changes in human and non-human primate white matter: from myelination disturbances to cognitive decline.

Authors:  Steven G Kohama; Douglas L Rosene; Larry S Sherman
Journal:  Age (Dordr)       Date:  2011-12-28

9.  Beneficial effects of minocycline on cuprizone induced cortical demyelination.

Authors:  Thomas Skripuletz; Elvira Miller; Darius Moharregh-Khiabani; Alexander Blank; Refik Pul; Viktoria Gudi; Corinna Trebst; Martin Stangel
Journal:  Neurochem Res       Date:  2010-06-11       Impact factor: 3.996

Review 10.  The development of myelin repair agents for treatment of multiple sclerosis: progress and challenges.

Authors:  Robert P Murphy; Keith J Murphy; Mark Pickering
Journal:  Bioengineered       Date:  2012-11-12       Impact factor: 3.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.